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Background
A key feature of Staphylococcus aureus biology is its ability to switch from an apparently benign
colonizer of ~30% of the population to a cutaneous pathogen, to a deadly invasive pathogen. Little is known about the mechanisms driving this transition or the propensity of different S. aureus
strains to engender different types of host-pathogen interactions. At the same time, significant
weight has been given to the role of specific in vitro phenotypes in S. aureus virulence. Biofilm
formation, hemolysis and pigment formation have all been associated with virulence in mice.

Design
To determine if there is a correlation between in vitro phenotype and the three types of hostpathogen relationships commonly exhibited by S. aureus in the context of its natural human
host, we assayed 300 clinical isolates for phenotypes implicated in virulence including
hemolysis, sensitivity to autolysis, and biofilm formation. For comparative purposes, we
also assayed phenotype in 9 domesticated S. aureus strains routinely used for analysis of
virulence determinants in laboratory settings.

Results
Strikingly, the clinical strains exhibited significant phenotypic uniformity in each of the
assays evaluated in this study. One exception was a small, but significant, correlation
between an increased propensity for biofilm formation and isolation from skin and soft tissue
infections (SSTIs). In contrast, we observed a high degree of phenotypic variation between
common laboratory strains that exhibit virulence in mouse models. These data suggest the
existence of significant evolutionary pressure on the S. aureus genome and highlight a role
for host factors as a strong determinant of the host-pathogen relationship. In addition, the
high degree of variation between laboratory strains emphasizes the need for caution when
applying data obtained in one lab strain to the analysis of another.
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Introduction
Staphylococcus aureus is an important gram-positive pathogen that colonizes the skin and
mucosal membranes of 30% of the population [1]. While generally associated with minor skin
infections, S. aureus can also be associated with more invasive disease. S. aureus is a highly successful pathogen in part because it has numerous functionally redundant virulence factors
[2,3]. S. aureus’ ability to acquire antibiotic resistance without a significant impact on growth
or virulence has made it a serious public health concern [4,5].
A common cause of nosocomial infections, S. aureus can become epidemic within hospitals
where it is easily passed between patients and healthcare providers. Up to 75% of newborns are
carriers of S. aureus by the time they are 5 days old [6]. Methicillin-resistant S. aureus (MRSA)
was historically limited to patients with significant healthcare exposure, and these healthcareassociated MRSA strains are particularly problematic due to the limited number of antibiotics
available for treatment. Recently evolved community-associated MRSA (CA-MRSA) infections
are an emerging public health problem. CA-MRSA outbreaks are generally associated with
superficial skin and soft tissue infections (SSTI), however there have been cases of invasive
and sometimes deadly diseases that account for ~20,000 deaths per year. The emergence
of CA-MRSA and the pre-existing prevalence of MRSA in hospital settings have made S.
aureus the most deadly infectious agent in the United States [7].
Much of what we know about the physiology and virulence of S. aureus has been elucidated
through genetic disruption of assayable phenotypes in one of several domesticated laboratory
strains and subsequent analysis of virulence in mouse models. Although many such studies
have speculated that particular virulence determinants may be associated with a particular
host-pathogen interaction, we know little about the factors that underlie these interactions in
clinical settings.
Here we present comparative phenotypic data from the analysis of 9 strains of S. aureus
commonly used in virulence studies as well as 300 CA-MRSA clinical isolates that have been
subject to minimal passaging. We utilized a number of laboratory assays that have been correlated with staphylococcal virulence in mouse models to examine the extent of phenotypic variation in this collection of “wild type” S. aureus strains. Our observations reinforce the need to
use caution when developing models for S. aureus virulence mechanisms using these profoundly different strains.

Experimental Design
To identify S. aureus determinants correlated with three types of host-pathogen interaction:
commensal, SSTI, and invasive infection, we subjected 9 domesticated “wild type” laboratory
strains and 300 clinical isolates of S. aureus to systematic phenotypic analysis. The nine, highly
passaged, laboratory strains included four laboratory strains commonly used for the study of S.
aureus virulence (NCTC 8325, SH1000, Newman, UAMS1), two health care acquired methicillin resistant strains (N315 and Mu50), and three community acquired methicillin resistant
strains (USA400 MW2, USA 300 TCH1516, and USA300 FPR3757). The three hundred clinical isolates were obtained between 2008 and 2011 from patients at St. Louis Children’s Hospital
(SLCH) and subjected to only minimal passaging.

Domesticated laboratory strains
NCTC 8325 is the progenitor strain of the 8325 lineage and one of the first reported sequenced
genomes of S. aureus [8]. Members of this lineage are often used as model organisms in many
facets of laboratory research [9,10]. SH1000 is an NCTC 8325 derivative that has been cured of
its 3 prophages and is frequently employed for biofilm studies [9]. Newman, was isolated from
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a human infection and is described as having a “robust” virulent phenotype [11]. Finally,
UAMS1 was isolated from a biopsy of an osteomyelitis patient and is frequently employed in
studies of musculoskeletal infections [12]. All of these strains have been passaged for many
years. Newman and NCTC8325 in particular were isolated in 1943 and 1952 respectively
[8,11].
HA-MRSA strains. In addition to methicillin-sensitive S. aureus (MSSA) strains, we also
compared two methicillin-resistant healthcare associated-MRSA strains, N315 and Mu50
(Table 1). MRSA origin strains N315 and Mu50 were isolated from patient infections in 1982
and 1997 respectively [13]. The Mu50 strain shows intermediate resistance to the glycopeptide
antibiotic vancomycin, which is commonly used in the treatment of serious MRSA infections.
Intermediate susceptibility to vancomycin (VISA) is associated with persistent S. aureus infections, and results from a variety of mutations in cellular processes including cell wall synthesis,
transport, toxin synthesis, antibiotic resistance, and metabolism. A key feature of VISA strains
is a reduced growth rate and corresponding small colony phenotype associated with aberrant
cell wall turnover and altered metabolic function [14].
CA-MRSA strains. Three CA-MRSA strains were also included in the study: USA400
MW2, USA 300 TCH1516, and USA300 FPR3757 (Table 1). USA400 MW2, isolated in 1998,
caused the first recorded fatalities attributed to a MRSA infection acquired outside the hospital
[15]. USA300 FPR3757 was isolated in 2002, from the wound infection of a patient with a
SSTI, while USA300 TCH1516 isolated in 2001, was taken from the blood of a patient suffering
from severe sepsis [16,17]. Comparisons of the whole genome sequence of these 2 strains have
revealed just 34 non-synonymous SNPs in proteins of various functions [17]. However no previous data exists on phenotypic differences associated with these changes other than antibiotic
susceptibility profiles.

Clinical Isolates
Clinical isolates were collected from various body sites (e.g. nares, soft tissue, blood, and bones)
and following minimal manipulation to select for single colonies and test for antibiotic susceptibility, frozen and stored. These strains represent 3 different classes of S. aureus hostpathogen interactions, given the tissues from which they were collected (39%-colonization,
50%-SSTI, 11%-invasive). Of the 300 clinical isolates examined, 95% were sequence typed as
Table 1. S. aureus strains.
Strain

Description

NCTC
8325

Standard laboratory strain. Propagating strains for phage 47.

SH1000

Standard laboratory strain. Man made derivative of NCTC 8325 that has been cured of
prophages with functional rsbU.

Newman

Standard laboratory strain. Isolated from human infection and used extensively in animal
models of staphylococcal disease.

UAMS1

Standard laboratory strain. Isolated from biopsy of osteomyelitis patient. Used in virulent
studies of staphylococcal disease.

Mu50

Vancomycin-intermediate strain isolated from wound of infected patient.

N315

Methicillin-resistant strain isolated from respiratory tract of infected patient.

TCH1516

Strain type USA300. CA-MRSA isolated from otherwise healthy patient. Used in virulence
studies in mouse model systems.

FPR3757

Strain type USA300. CA-MRSA isolated from wound of HIV positive intravenous drug user.

MW2

Strain type USA400. CA-MRSA strain isolated from blood of infected patient.

doi:10.1371/journal.pone.0129670.t001
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being USA300/ST8 (multilocus sequence type 8, clonal complex 8, staphylococcal cassette
chromosome mec type IV), the predominant cause of community acquired MRSA in the
United States [18]. Note that the number of invasive isolates used in this study is an overrepresentation relative to average patient intake at SLCH.

Results
Pigment formation is highly variable in reference strains
Differences in growth rate, colony size, and colony pigment have been associated with S. aureus
virulence and antibiotic sensitivity [19–22]. A prime example is S. aureus strains with an intermediate sensitivity to vancomycin, which is known to have a growth defect in rich medium
[13,23,24]. Similarly, pigment color can be a strong indicator of S. aureus environmental phenotype. The golden color of S. aureus is associated with the production of the pigment staphyloxanthin, which is involved in host evasion [6]. Unpigmented strains of S. aureus succumb to
the immune system more rapidly than pigmented strains [20,21,25].
To identify physiological costs associated with different adaptive mutations we evaluated
the growth properties of the 9 domesticated strains of S. aureus in Tryptic Soy Broth (TSB).
We observed S. aureus isolates relative growth rates, cell density, and survival potential in stationary phase. Single colonies of S. aureus were inoculated into TSB and grown overnight at
37°C with shaking. Following overnight incubation, cultures are diluted back to an OD600 of
~0.05 and grown at 37°C with shaking. Optical density was measured every 30 minutes. We
also observed the colony morphology of each of the clinical isolates and control strains on solid
Tryptic Soy Agar (TSA) media to identify changes in pigment formation.
Comparisons of the growth rates of each domesticated staphylococcal strain revealed very
few differences in cell densities and mass doubling times. As expected the VISA strain Mu50
grew substantially slower in Tryptic Soy Broth (TSB) when compared to the other reference
strains (Fig 1B). This growth property is common amongst VISA isolates and is thought to be
due to defects in cell wall biosynthesis [14]. Also Mu50, plated on TSA plates appeared smaller
by visual analysis, than the related N315 strain and the other laboratory strains. Observations
of the domesticated laboratory strains plated on TSB agar revealed a distinct difference in the
pigmentation of SH1000 and its progenitor strain NCTC 8325 (Fig 1A). Comparisons of the
two USA300 strains directly exhibited differences in both growth rates and yields. USA300
TCH1516 grows slower in TSB media than its subclone USA300 FPR3757 (Fig 1B). There were
also morphological distinctions when comparing the three USA300 strains. TCH1516 formed
small, unpigmented colonies on TSA plates, while FPR3757 and MW2 both formed larger
golden colonies under identical growth conditions (Fig 1A).

Sensitivity to TX100 Autolysis varies as much as 10-fold in reference
strains
Bacterial autolysis is the self-digestion of a cell through the actions of its own peptidoglycan
hydrolases. Because of the lethality associated with compromised cell wall integrity, the actions
of these enzymes are tightly regulated. Perturbations of autolysis have been associated with
defects in cell wall synthesis or cell wall turnover, antibiotic resistance, and virulence [26,27].
We tested the autolytic activity of each of the domesticated strains of S. aureus by exposing
them to low concentrations of Triton X-100 (TX-100). Single colonies were grown as described
above. Upon reaching stationary phase, cultures are chilled on ice to halt growth. Chilled cultures are then centrifuged at 15,000rpm and re-suspended in autolysis buffer containing TX-

PLOS ONE | DOI:10.1371/journal.pone.0129670 June 22, 2015

4 / 20

Limited Phenotypic Variation in S. aureus Clinical Isolates

Fig 1. Colony morphology and growth rate variability in reference strains of S. aureus. (A)
Domesticated strains of S. aureus were streaked onto TSA plates and grown overnight at 37°C. Following
incubation images were observed for differences in color and size. (B) We observed S. aureus isolates
relative growth rates, cell density, and survival potential in stationary phase. Single colonies of S. aureus were
inoculated into TSB and grown overnight at 37°C with shaking. Following overnight incubation cultures are
diluted back to an OD600 of ~0.05 grown at 37°C with shaking. Optical density was measured every 30
minutes.
doi:10.1371/journal.pone.0129670.g001

100. Sensitivity to TX-100 autolysis was reflected by a decrease in optical density upon exposure to TX-100.
The 9 domesticated strains exhibited tremendous variability in their autolytic activity following exposure to TX-100. NCTC8325 and Mu50 were highly sensitive to autolysis by TX100, relative to related strains N315 and SH1000 respectively (Fig 2A and 2B). The OD600 of
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Fig 2. Sensitivity to autolysis varies <10 fold in reference strains. We tested the autolytic activity of each
reference strain of S. aureus by exposing them to low concentrations of Triton X-100. Sensitivity to autolysis
was reflected by a decrease in the OD600 upon exposure to TX-100. There was significant variability in
sensitivity amongst the (A) Laboratory strains (B) HA-MRSA strains and (C) CA-MRSA strains of S. aureus
observed in this assay.
doi:10.1371/journal.pone.0129670.g002
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both NCTC8325 and Mu50 decreased rapidly two hours after exposure to the detergent (Fig
2A and 2B). This result was consistent with previous observations that Mu50 loses viability
rapidly [28]. Strains Newman, N315, and UAMS1 were resistant to autolysis by TX-100 at the
concentrations used in this assay. The CA-MRSA strains also exhibited a high degree of divergence with regard to autolytic susceptibility. Strain TCH1516 was highly susceptible (~10-fold)
to autolysis by TX-100 when compared to its counterpart FPR3757 (Fig 2C), suggesting compromised cell wall or cell membrane integrity.

The laboratory strains Newman and UAMS1, together with slow growing
HA and CA-MRSA strains exhibit poor biofilm formation
Biofilm formation is thought to play a key role in S. aureus virulence. Biofilms have been implicated in invasive S. aureus infections and may be particularly important for the first step in
pathogenesis, colonization [29,30]. Biofilms protect the bacteria from the host immune system
increasing nonspecific antibiotic resistance [29,30]. S. aureus biofilm formation on indwelling
medical devices has been associated with nosocomial infections including pneumonia [29–31]
To determine the relative ability of the domesticated S. aureus strains to form biofilms we
used a standard 96-well plate assay on each of our staphylococcal strains (Materials and Methods). Single colonies of S. aureus were grown overnight in TSB + glucose. Cultures were backdiluted to an OD600 of 0.005 in TSB + glucose and 100ul aliquots of each strain are plated in
triplicate in 96 well microtiter plates. Microtiter plates were grown statically at 37°C for 24hrs.
The domesticated strains tested in the biofilm assays exhibited a high degree of variation
(Fig 3).
SH1000, the standard strain for biofilm related studies, exhibited consistently strong biofilm
formation, >5-fold higher than Newman and UAMS1. Strain N315 also formed robust biofilms near the density of SH1000, however closely related Mu50 is a poor biofilm forming
strain. Neither of the CA-MRSA strains MW2, TCH1516 nor FPR3757 were strong biofilm
formers (Fig 3). We speculate that slow growth is a major contributor to the poor biofilm forming ability exhibited by Mu50 and TCH1516.

Hemolytic activity differs significantly between closely related
laboratory, CA-MRSA and HA-MRSA strains
Host cell lysis is a key feature of a broad range of pathogens. Lysis is a means to obtain nutrients
such as iron from the host cells [32,33]. Absence of hemolysis in S. aureus has been correlated
with the down-regulation of either α or β-hemolysins, or mutations in the agr quorum sensing
system [3,33–36]. Hemolysis is central to S. aureus ability to invade, colonize and obtain nutrients, particularly iron. Defects in hemolytic ability are associated with decreased virulence in
mouse model systems [3,33–36]. A previous study done by Malachowa et al reported significant differences in the transcriptional profiles of S. aureus strains grown in blood compared to
TSB [37]. The list of blood dependent up-regulated genes included numerous cytolytic toxins
including hla, hld, and hlgABC [37].
To assess hemolytic activity, single colonies of S. aureus were grown up to exponential
phase in TSB, then back-diluted to an OD600 of ~0.05. Diluted cultures are then spotted on
TSA plates supplemented with 5% sheep’s blood and incubated for 48hrs. Following incubation
the “zones of hemolytic clearing” were measured and recorded.
There was significant variation of hemolytic activity amongst the domesticated strains of S.
aureus including the closely related strains, NCTC 8325 and SH1000. A large zone of hemolysis
was observed for NCTC 8325 that was approximately three times the size of that observed for
SH1000 (Fig 4B). Three strains, UAMS1, N315, and Mu50 showed no hemolytic activity in this
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Fig 3. Laboratory strains Newman and UAMS1, together with slow growing HA and CA-MRSA strains exhibit poor biofilm formation. To determine
the relative ability of S. aureus to form biofilms we used a standard 96-well plate assay on each of our staphylococcal strains [70,71]. (A) Single colonies of S.
aureus were grown overnight in TSB + glucose. Cultures were backdiluted to an OD600 of 0.005 in TSB + glucose and 100ul aliquots of each strain are plated
in triplicate in 96 well microtiter plates. Microtiter plates were grown statically at 37°C for 24hrs. Unattached cells are discarded and the remaining attached
cells are then stained with crystal violet. Results depicted here represent the mean and standard deviation of 12 replicates of each reference strain type (B)
Representative image of the crystal violet staining of microtiter plates for each reference strain. Images are taken from above.
doi:10.1371/journal.pone.0129670.g003

assay. The three CA-MRSA strains also exhibited a wide range of variation with regard to
hemolytic activity, with zones of clearing in TCH1516, FPR3757, and MW2 showed 9mm,
4mm and 1mm zones respectively, indicating a significant difference in each strain’s ability to
lyse sheep red blood cells (Fig 4A and 4B).

The hyperhemolytic CA-MRSA strain TCH1516 is dependent on
exogenous heme for growth
In the course of this investigation we noticed that USA300 TCH1516 exhibited extremely poor
growth on TSA but growth was significantly improved on TSA + 5% sheep’s blood. This is in
contrast to the other reference strains, which grew equivalently on TSA media in presence and
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Fig 4. Hemolytic activity differs significantly between closely related laboratory, CA-MRSA and HA-MRSA
strains. (A) Hemolytic activity was assessed by growing single colonies of S. aureus up to exponential phase in
TSB, then back-diluted to an OD600 of ~0.05. Diluted cultures are then spotted on TSB agar plates supplemented
with 5% sheep’s blood and incubated for 48hrs. Following incubation the “zones of hemolytic clearing” are
measured and recorded. (B) Graphical representation of the “zones of hemolytic clearing” observed in reference
strains. Data shown is average of 3 biological replicates. Error bars represent standard deviation.
doi:10.1371/journal.pone.0129670.g004
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absence of 5% sheep’s blood. Even Mu50, the VISA strain, exhibited equivalently poor growth
regardless of medium.
In light of its enhanced growth on sheep’s blood, we speculated that the root cause of the
TCH1516 growth defect was a heme deficiency. Since TCH1516 was isolated from human
blood, it is possible that it lost the ability to synthesize heme during its transition from commensal to invasive infection. To test this possibility, we compared the growth of TCH1516,
FPR3757, and Newman on TSA, TSA supplemented with human hemoglobin, and TSA + 5%
sheep’s blood. Briefly, TCH1516, FPR3757, and Newman were grown up to exponential (OD
~0.5), backdiluted to OD600 of ~0.05, and serially diluted (10−1–10−5) on either TSA plates or
TSA plates supplemented with human hemoglobin or sheep’s blood.
Consistent with observations of heme deficient strains, supplementing the solid medium
with 50ug/ml or 200ug/ml of hemoglobin or 5% sheep’s blood substantially improved the
growth of the USA300-TCH1516 strain (Fig 5) but had little impact on the relatively robust
growth of Newman and FPR3757. Based on these findings, we speculate that USA300
TCH1516 is a heme auxotroph. Consistent with this idea, sequence analysis revealed allelic differences in the heme biosynthetic pathway of TCH1516 [17]. We will address the significance
of these SNPs in discussion.

Clinical Isolates of USA300 demonstrate phenotypic homogeneity
regardless of their origin
We assayed ~300 clinical isolates of S. aureus for three different phenotypes (pigment formation, hemolysis, acetate utilization) that have been implicated in virulence to examine if there is
a correlation between laboratory phenotype and a given type of host-pathogen interaction.
Our collection of clinical strains includes isolates from the three clinical entities; skin and
soft tissue infections, invasive infections, and sites of colonization (commensal). Multidrugresistant and multidrug-susceptible strains are included in the collection; however there is no
correlation between clinical presentation and multidrug resistance [3]. The majority, (285/300;
95%) of these isolates have been classified as ST8 (USA300), a community-acquired S. aureus
variant that can acquire multidrug resistance.
The 300 clinical isolates were considerably more homogeneous with regard to colony morphology, hemolysis activity, and acetate utilization than the laboratory strains. While we saw
some bias in biofilm forming ability, particularly with regard to isolates sampled from SSTIs,
this bias was quite modest. Also we did not observe any significant differences between the ST8
strains and the 15 “other” strain types. Below we detail our findings for each of the three phenotypic assays.
Colony Pigment. Colony pigment was assessed on TSA plates after 24-hour incubation at
37°C as described above for laboratory strains. An overwhelming majority (96%) of the strains
examined were the deep gold characteristic of wild type S. aureus. Surprisingly, invasive strains
were more likely to have a white colony pigment (16%) than colonizing or SSTI strains (both
3%; p = 0.002) (Table 2). Down-regulation of the staphyloxanthin pigment has been associated
with evasion of the human immune system [20,21,25]. The ability of many CA-MRSA strains
to escape the host immune response undoubtedly enhances their ability to become an infectious agent.
Hemolytic activity. The hemolytic activity of all 300 clinical isolates was evaluated based
on the zone of clearing around single colonies plated on TSA + 5% sheep’s blood, as described
above. TCH1516 (high hemolysis >5mm), FPR3757 (intermediate hemolysis between 1-5mm)
and UAMS1 (no hemolysis <1mm) were used as reference strains. Plates were observed following 24hr incubation at 37°C. Each colony was examined for altered hemolytic phenotypes.
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Fig 5. The hyperhemolytic CA-MRSA strain TCH1516 is hemoglobin-dependent for growth. TCH1516, FPR3757 and Newman were grown up to
exponential (OD ~0.5) backdiluted to OD600 of ~0.05, and serially diluted (10−1–10−5) on either TSA plates or TSA plates supplemented with human
hemoglobin or sheep’s blood.
doi:10.1371/journal.pone.0129670.g005

A large majority (91%) of the observed strains had an intermediate phenotype, similar to
FPR3757 (Fig 4). Colonizing (14%) and invasive (13%) strains showed a higher incidence of
altered hemolytic activity than SSTI (5%) strains, though this difference did not reach statistical
significance (Table 2).
Table 2. Statistical analysis of phenotype variation in clinical isolates.
Total
N = 300 (%)

Colonization
N = 117 (%)

SSTI
N = 151 (%)

Invasive
N = 32 (%)

p-value

0.002

Colony Morphology
Gold

288 (96)

114 (97.4)

147 (97.4)

27 (84.4)

White

12 (4)

3 (2.6)

4 (2.6)

5 (15.6)

Low/none

13 (4.3)

8 (6.8)

3 (2)

2 (6.3)

Intermediate

272 (90.7)

101 (86.3)

143 (94.7)

28 (87.5)

High

15 (5.0)

8 (6.8)

5 (3.3)

2 (6.3)

Hemolytic Activity
0.186

Acetate Utilization
Positive

287 (95.7)

112 (95.7)

147 (97.4)

28 (87.5)

Negative

13 (4.3)

3 (4.3)

4 (2.6)

4 (12.5)

0.045

doi:10.1371/journal.pone.0129670.t002
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Acetate utilization. The TCA cycle in S. aureus is activated in the stationary growth phase
as glucose levels decrease and acetate increases [38]. Inactivation of the TCA cycle has been
shown to disrupt many factors related to host-pathogen interactions including virulence, survival, and persistence [28,38–42]. In S. aureus the ability to catabolize acetate in the postexponential growth phase has been correlated to increased virulence factor production [38].
The inability to generate energy through the oxidation of acetate is associated with resistance
to oxidative stress and reduced susceptibility to antibiotics [41]. We evaluated the variation of
acetate catabolism in the stationary growth phase of 300 clinical isolates of S. aureus.
Acetate utilization was evaluated in cells cultured in TSB media and phenol red as pH indicator as described by Greg Somerville (Personal Communication). Acetate catabolism is evidenced by a color change from yellow to pink after overnight (~18 hours) of growth in TSB
+ indicator medium at 37°C. An acidic pH is indicative of an inability to utilize acetate.
Consistent with the idea that the TCA cycle has an important role in S. aureus physiology,
the overwhelming majority of the 300 clinical isolates we evaluated were positive for acetate
catabolism (96%) as judged by visual analysis. While invasive strains (88%) were statistically
(p = 0.045) less likely to efficiently utilize acetate than colonizing (96%) or SSTI (97%) strains,
the physiological basis for this difference is not readily apparent (Table 2).
Biofilm formation. As discussed in the previous section, biofilm formation has been
strongly implicated in virulence in laboratory strains of S. aureus, particularly SH1000
[29,30,43,44]. In particular, it has been suggested that the ability to form biofilms enhances S.
aureus resistance to disinfectant and antibiotic treatment, as well as to colonize abiotic surfaces
and human skin. The latter is particularly important because of the potential to become a reservoir for infections in both hospital and community settings [31].
To determine if differences in biofilm forming ability correlate with different types of hostpathogen relationships, we assessed relative biofilm formation in a microtiter plate assay in a
subset of the 300 S. aureus clinical isolates. These 96 strains included the entirety of invasiveinfecting strains (32 total), and 32 randomly selected strains from SSTI and colonization strains
respectively.
Supporting the idea that environmental surfaces contribute to the transmission
of CA-MRSA [31,45–47], we did observe a small, but significant, correlation between biofilm
potential and SSTIs infections (Fig 6). SSTI strains (0.55 ± 0.16) had higher relative biofilm formation than colonizing strains (0.19 ± 0.09) and invasive strains (0.15 ± 0.06; p<0.001,
Table 2).

Discussion
Several conclusions can be drawn from this study. First and foremost, our finding that domesticated S. aureus strains exhibit a high degree of phenotypic variation highlights the well known
problems associated with repeated passaging and mutagenesis of bacterial stocks [48–53]. Significantly, although all the domesticated strains are virulent in mouse models, several of the
phenotypes that exhibited the highest degree of variation have been implicated in S. aureus virulence, including biofilm formation and hemolysis. In contrast to the laboratory strains, minimally passaged clinical isolates exhibited only modest phenotypic variation regardless of
origin. The latter finding is consistent with data from other laboratories suggesting that S.
aureus is under a high degree of selective pressure in the “wild”[54]. Below we discuss the
implications of this work.
Phenotypic analysis of the nine domesticated S. aureus strains is consistent with a high
degree of genetic drift, leading to differential regulation of agr [3,35,55–57]. This is not surprising for older strains such as NCTC8325 and Newman, which were originally isolated 71 and 62
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Fig 6. Correlation of biofilm forming potential and SSTI isolates of CA-MRSA clinical isolates. Biofilm formation was assessed using microtiter assay
as described previously for 96 clinical isolates of S. aureus representing 3 different types of host-pathogen interactions. Distribution of data is shown by
scatter plot. Each data point is representative of the mean OD600 of 9 replicates of each individual isolate relative to the SH1000 reference strain. Relative
biofilm formation mean ± SD for each host-pathogen interaction is shown.
doi:10.1371/journal.pone.0129670.g006

years ago respectively, but is somewhat unexpected in more recent isolates such as TCH1516
and FPR3757. In particular, genetic differences in hemolytic capacity and biofilm formation
are likely related to agr status of individual strains [58,59]. agr positive strains often exhibit
strong hemolysis and poor biofilm formation and agr negative strains, exhibit poor hemolysis
and a strong propensity for biofilm formation. Like many non-virulent bacterial models
including E. coli K12 derivatives, several of these strains have been subjected to mutagenesis in
the course of their natural history to make them more tractable. SH1000, a man made strain
commonly used for biofilm studies, is itself a derivative of NCTC8325 that was subjected to
mutagenesis to cure prophage and subsequent repair of rsbU [9,10]. It is perhaps thus not surprising that SH1000 and its parent strain NC8325 are phenotypically divergent with regard not
only to colony pigment, but also sensitivity to autolysis, biofilm forming potential, and hemolysis of sheep’s blood (Figs 1, 2, 3 and 4).
At the same time, the high degree of variation we observed in phenotypes implicated in virulence, particularly biofilm formation and hemolysis, is surprising as all of the domesticated
strains, with the exception of NCTC8325 and Mu50, are employed more or less interchangeably for studies of virulence determinants in mouse models. Our findings thus highlight not
only the robust nature of S. aureus pathogenesis and the depth of its virulence “arsenal”, but
also the need for caution when assessing the significance of individual virulence determinants
in S. aureus infection.
Although phenotypic observations revealed significant variation amongst all the strains,
the CA-MRSA strain TCH1516 emerged as an outlier. We speculate that TCH1516 lost the
ability to synthesize heme in the heme rich environment of the host circulatory system, and
thus acquired this “hyper-hemolytic” ability as a means to compensate. Closer examination of
the sequence of TCH1516 revealed several mutations that may contribute to the strain’s unique
phenotype. One such mutation is in hemE, a precursor for heme biosynthesis in S. aureus [17].

PLOS ONE | DOI:10.1371/journal.pone.0129670 June 22, 2015

13 / 20

Limited Phenotypic Variation in S. aureus Clinical Isolates

Defects in heme biosynthesis, similar to defects in menaquinone biosynthesis, have been associated with the small colony variant (SCV) phenotype [60–63].
Another possible contributor to the peculiar phenotype of USA300 TCH1516 is the mutation in an AraC family transcriptional regulatory (AFTR) protein [17]. Proteins in this family
are regulators of carbon metabolism, stress response, and virulence that respond to changing
environmental conditions [64–66]. Mutations in AFTRs have previously been associated with
the transition of a colonizing strain of S. aureus to one that caused an invasive septic infection
[67]. Further examination of this class of proteins will be necessary to pinpoint a specific role
in S. aureus metabolic adaptation to the bloodstream.
In contrast to the domesticated strains, we observed little phenotypic variation between the
300 minimally passaged clinical isolates. At the same time, we did observe small but significant
correlations between host-pathogen interaction and three of the four phenotypes tested. These
included a modest but statistically significant increase in the frequency of invasive isolates with
defects in pigment formation and acetate utilization, as well as tendency of SSTI isolates to
exhibit slightly higher levels of biofilm formation (Table 2). While the underlying cause of the
former is unclear, the latter correlation is consistent with the idea that these types of infections
are biased towards those bacteria best able to “stick” to abiotic surfaces. The ability of
the CA-MRSA clinical isolates to attach to inert surfaces promotes transmission and enhances
their capacity to cause further infections [31,45]. At the same time, the correlation was modest.
Being a low “performer” with regard to biofilm forming ability is not necessarily a barrier to
entry so to speak when it comes to initiating an SSTI.
Phenotypic uniformity among the clinical isolates is consistent with a high degree of evolutionary pressure on S. aureus from both host and environmental factors. For example, colonization of the epidermis is dependent upon evasion of host-specific cutaneous defenses
mediated by toll-like receptors [31,68]. S. aureus must also contend with the presence of commensal bacteria such as Staphylococcus epidermidis on the host. S. epidermidis has also been
shown to directly inhibit S. aureus colonization in preferred environmental niches [31,68].
The high degree of phenotypic uniformity between clinical isolates regardless of origin, suggests that stochastic events and host-specific factors are more important determinants of
the host-pathogen relationship than variations between individual S. aureus strains. This idea
is not new. Ruimy et al. reported that host-associated factors are the predominant determinant
of S. aureus nasal carriage [54]. Similarly, a 15 month evaluation of the genome sequence of
persisting S. aureus strains by Uhlemann et al, revealed the accumulation of mutations in genes
involved in all aspects of host colonization [45]. This observation of variance in the S. aureus
genome over time is consistent with the idea that host biology is a critical determinant of the S.
aureus host-pathogen relationship. We anticipate that future work investigating the contribution of host factors to S. aureus pathogenesis will strengthen our knowledge of virulence factor
evolution as well as give insights to the transmission and spread of staphylococcal disease.

Materials and Methods
Strains & Growth Conditions
All S. aureus strains are listed in Table 1. S. aureus was cultured in Tryptic Soy broth (TSB)
medium unless otherwise noted and cells were grown at 37°C. Unless otherwise stated cultures
are grown from a single colony until mid-log (OD600 of ~0.2 – 0.6), then diluted to an OD600 of
~0.05 and grown to mid-log again and used for further study.
With regard to the clinical strains, wound isolates were sampled directly from the source of
infection and plated directly to blood agar. Single colonies were sub-cultured once on solid
medium for purity and again for antibiotic susceptibility prior to freezing. Colonization isolates
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(nose, armpit, groin), were subjected first to a broth enrichment step in Trypiticase soy broth
with 6.5% NaCl prior to colony purification and testing for antibiotic susceptibility

Dilution Plating
S. aureus strains USA300 TCH1516 and USA300 FPR3757 were dilution plated similarly to
previous description [69]. Cells were grown to stationary phase in TSB medium, and then
diluted back to an OD600 of 0.05 upon which serial dilutions of 10−1 to 10−5 were made into
fresh TSB medium. 5ul of each dilution was then plated in series onto either prewarmed Tryptic Soy Agar (TSA), TSA II plates + 5% sheep’s blood (Fisher), or TSA plates
supplemented with Human hemoglobin (Hb) (Sigma). Liquid cultures were allowed to dry on
plates for up to an hour, and then plates were incubated at 37°C overnight. The plates were
then imaged and the relative growth at each media condition was qualitatively assessed.

Hemolysis Plating
Single colonies of S. aureus are inoculated in triplicate to 5ml of TSB media. Cultures are
grown with shaking at 37°C to mid-log (OD600 0.2–0.6). Cultures are then diluted to an OD600
of 0.05 in a microcentrifuge tube. 5ul of diluted cultures are spotted onto TSA plates with 5%
sheep’s blood agar [69] and incubated at 37°C for 48hrs. After 48hrs zones of hemolysis are
observed and measured. Plate images are scanned and saved.

Biofilm Assay
S. aureus is grown from single colonies to mid log (OD600 0.2 – 0.6) in 5mls of TSB media. Culture is diluted to OD600 0.05 in TSB media + 0.5% glucose. 200ul of each culture is then aliquoted into 96 well polystyrene plates. 96 well plate is covered and incubated statically at 37°C
for 24hrs. After 24hr period media with non-attached cells is discarded. 96 well plates are then
washed 3 times with de-ionized water. Plates are air-dried for at least 15 minutes. 200ul of ethanol is added to each well for 1 min, and then removed using pipet. Plates are then allowed to
air dry for at least 5 minutes. All wells are then stained with 200ul of 0.5% crystal violet for 10
minutes at room temperature. After 10-minute incubation period crystal violet is discarded
and 96 well plates are washed 3 times with DI water. All wells are washed with 33% acetic acid,
and then diluted 1:10 in distilled water. OD595 is then measured using a spectrophotometer.

Autolyis Assay
Strains of S. aureus are streaked from ice onto TSA plates + 5% sheep’s blood and grown overnight at 37°C. Single colonies are picked for each strain and grown in 5ml TSA media with aeration until stationary phase (OD600 > 1.5). Cultures are then backdiluted to an OD600 of
~0.05 in 2ml of TSA media and grown for 3–5 hours at 37°C with aeration to midexponential phase (OD600 ~0.7–1.0). Following 3–5 hours of growth, cultures are quickly
chilled on ice for 10 minutes and 1ml aliquots are harvested by centrifugation (3,200 x g for
5min at 4C). Supernatant is discarded and remaining pellet is washed with ice-cold water once
and then re-suspended in autolysis buffer (0.5M Tris-HCl pH 7.5, 0.05% TX-100) [26,27].
100ul of each strain is then added to 96 well microtiter plates in triplicate. S. aureus strains are
grown at 37°C with aeration in microtiter plates using BioTek Eon. OD600 readings are taken
every 30min.
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Screen for loss of acetate metabolism
Strains of S. aureus are streaked from ice onto TSA plates + 5% sheep’s blood and grown overnight at 37°C. Single colonies are picked for each strain and grown in 2ml TSA media containing 1ml/L of a 1% solution of Phenol red. Ratio of growth container to culture medium ration
should be at least 10:1. Culture tubes are incubated at a 45-degree angle to allow for maximum
aeration, and shaken at 225rpm. S. aureus strains are grown overnight (12 – 18 hours) at 37°C.
The media is observed for color changes after overnight growth. Yellow cultures are indicative
of an acidic pH. Experiment was done in duplicate on three separate days for each strain.

Statistical analysis
Data were analyzed using SPSS 22 for Windows (IBM SPSS, Chicago, IL). Phenotypic differences between the three categories of clinical S. aureus isolates (colonization, SSTI, and invasive
infection) were analyzed using the Pearson's χ2 test. All tests for significance were 2-tailed,
and p-values of <0.05 were considered significant.
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